P2 Multi-center Study of SB204 Gel in the Treatment of Acne Vulgaris

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2014
This is a randomized, multi-center, double-blinded study in subjects with moderate to severe acne vulgaris. Subjects eligible to enroll will be treated once or twice daily with 2 concentrations of a topical drug in development or a vehicle. Subjects will be treated for up to 12 weeks.
Epistemonikos ID: 51e65bd82202e5cc73cfee363a4d030633998ff2
First added on: May 12, 2024